Probiotics for your lungs

ResBiotic is pioneering microbiome-based nutritional products for respiratory health.

Transforming the $100B+ Respiratory Disease Market by Tackling a Primary Cause

Chronic respiratory illness is associated with lung dysbiosis (also known as an abnormal lung microbiome) in addition to local and systemic inflammation. An abnormal microbiome induces further inflammation, creating a downward spiral. ResBiotic’s supplement and medical food products are breaking this cycle and improve lung health.

Fully Integrated with the resources of University of Alabama at Birmingham

As the flagship brand of ResBiotech Innovation Institute, ResBiotic is supported by:

Bill Harbert Insititute for Innovation and Entrepreneurship

Licensing and commercialization

UAB Medicine
Lung Health

Scientific Research,
Lung Health

UAB School of Medicine Microbiome

Scientific Research,

Translational Research in Normal & Disordered Development

Scientific Research,
Human Development


ResBiotic is developing dietary supplements and medical foods to support lung health.

Probiotic Supplement

Our first product is a dietary supplement, targeting the gut lung axis with a proprietary probiotic blend clinically proven to support lung health.

Coming February 2022


Medical Foods

Our pipeline of medical foods includes proprietary synbiotic and nutritional formulas for individuals with chronic lung diseases.

 Coming September 2022

Lung Health Starts Here

Join us in revolutionizing the standard of care for chronic respiratory diseases.